Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier Versteeg

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Experimental Cell Research|January 19, 2008
The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastomaIngrid Revet, Gerda Huizenga, Alvin Chan, et al.
Genome Research|August 19, 2007
Domain-wide regulation of gene expression in the human genomeHinco J Gierman, Mireille H G Indemans, Jan Koster, et al.
BMC Bioinformatics|July 3, 2013
Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patientsDavide Cangelosi, Fabiola Blengio, Rogier Versteeg, et al.
Nucleic Acids Research|December 21, 2013
Discovery and visualization of miRNA-mRNA functional modules within integrated data using bicluster analysisKenneth Bryan, Marta Terrile, Isabella M Bray, et al.
Plos One|September 7, 2013
CD44 expression in intestinal epithelium and colorectal cancer is independent of p53 statusJurrit Zeilstra, Sander P J Joosten, Louis Vermeulen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulationDirk Geerts, Christopher J Wallick, Dana-Lynn T Koomoa, et al.
BMC Bioinformatics|April 28, 2012
Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcomeAndrea Cornero, Massimo Acquaviva, Paolo Fardin, et al.
Cancer Research|April 17, 2008
Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastomaJan J Molenaar, Marli E Ebus, Jan Koster, et al.
International Journal of Cancer|February 6, 2015
Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical useKristoffer von Stedingk, Katleen De Preter, Jo Vandesompele, et al.
International Journal of Cancer|April 3, 2003
High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell typeVera A E Van Limpt, Alvin J Chan, Peter G Van Sluis, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Experimental Cell Research|January 19, 2008
The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastomaIngrid Revet, Gerda Huizenga, Alvin Chan, et al.
Genome Research|August 19, 2007
Domain-wide regulation of gene expression in the human genomeHinco J Gierman, Mireille H G Indemans, Jan Koster, et al.
BMC Bioinformatics|July 3, 2013
Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patientsDavide Cangelosi, Fabiola Blengio, Rogier Versteeg, et al.
Nucleic Acids Research|December 21, 2013
Discovery and visualization of miRNA-mRNA functional modules within integrated data using bicluster analysisKenneth Bryan, Marta Terrile, Isabella M Bray, et al.
Plos One|September 7, 2013
CD44 expression in intestinal epithelium and colorectal cancer is independent of p53 statusJurrit Zeilstra, Sander P J Joosten, Louis Vermeulen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulationDirk Geerts, Christopher J Wallick, Dana-Lynn T Koomoa, et al.
BMC Bioinformatics|April 28, 2012
Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcomeAndrea Cornero, Massimo Acquaviva, Paolo Fardin, et al.
Cancer Research|April 17, 2008
Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastomaJan J Molenaar, Marli E Ebus, Jan Koster, et al.
International Journal of Cancer|February 6, 2015
Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical useKristoffer von Stedingk, Katleen De Preter, Jo Vandesompele, et al.
International Journal of Cancer|April 3, 2003
High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell typeVera A E Van Limpt, Alvin J Chan, Peter G Van Sluis, et al.
Pageof 15